Skip to main content

Table 3 Dietary intakes among the study groups at baseline

From: Effect of lysine supplementation on hypertensive men and women in selected peri-urban community in Ghana

  Lysine group1 Lysine group +1000 mg lysine2 Placebo group1
  Mean SD % Risk of inadequacy3 mean SD % Risk of inadequacy3 Mean SD % Risk of inadequacy3
Men n = 46    n = 46    n = 44   
Total Energy kcal 1709 386   1709 386   1772 399  
Total Protein g 51.35 14.51   51.35 14.51   53.37 13.35  
Total N g 8.22 2.32   8.41 2.32   8.18 2.28  
Utilizable Protein g 3 49.95 15.32 38.4 51.35 14.51 33.5 51.15 14.25 35.8
Lysine mg/kg/day 4 38.55 13.08 32.6 53.86 13.71 0 41.54 19.45 29.5
Sulfur Amino Acids mg/kg/day 4 23.49 6.93 10.9 23.49 6.93 10.9 24.74 9.22 11.4
Women n = 44    n = 44    n = 41   
Total Energy kcal 1406 483   1406 483   1435 335  
Total Protein g 42.88 13.75   42.88 13.75   45.05 13.80  
Total N g 6.86 2.2   7.05 2.20   6.98 2.25  
Utilizable Protein g3 40.82 13.65 56.6 42.87 13.76 51.2 43.65 14.10 58.7
Lysine mg/kg/day 4 32.20 12.34 50 48.41 13.99 11.4 33.44 16.94 48.8
Sulfur Amino Acids mg/kg/day4 20.00 7.43 31.8 20.00 7.43 31.8 19.69 8.23 39.0
  1. No significant differences in the lysine and control groups before adding lysine tested using independent sample t-test
  2. The group reveals the expected enhancement in baseline value of the lysine group nutrients on adding 1000 mg of lysine which is corresponding to the quantity of supplement supplied
  3. Percent at risk of protein deficiency, based on a requirement of protein of 0.66 g/kg intended for adults (WHO, 2007)
  4. Adult amino acid requirements: 30 mg/kg/day lysine, 15 mg/kg/day sulfur amino acids, 15 mg/kg/day threonine, 4 mg/kg/day tryptophan (WHO, 2007)
  5. Difference from placebo group, p < 0.001
Back to article page

BMC Nutrition

ISSN: 2055-0928

Contact us